• Trial(s) for Heart and Vascular Center

    Study Objective Contact
    A Randomized, Open Label, Multi-Center, Active-Controlled, Parallel Group Study to Determine the Efficacy and Safety of the REG1 Anticoagulation System Compared to Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention [LCID Study Number: 2013-067] This clinical trial will be looking at an investigational anticoagulant (blood thinning) medication in patients with Coronary Artery Disease (CAD) undergoing Percutaneous Coronary Intervention Procedure (PCI). Anticoagulants are given to thin the blood during the PCI procedure. This study is designed to determine the efficacy of REG1 compared to bivalirudin in preventing complications and major bleeding in patients undergoing PCI as a treatment for CAD. Principal Investigator(s):
    Christopher Pyne, MD

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Judy E. Pendleton.
    CELESTIAL Post Approval Registry (Corox OTW, Endocardial, Left VEntricular STeroId, LeAd, BipoLar Post Approval Registry) [LCID Study Number: 2009-060] The purpose of this Registry study is to confirm the long term safety and effectiveness of the Corox OTW (-S) BP LV Lead, a non-investigational lead. In this Registry, data will be collected on the leads that connect the CRT system to the ventricles. These leads are legally marketed in the United States and not investigational products. The U.S. Federal Drug Administration (FDA) is requiring the company, BIOTRONIK, to collect additional long term data on these leads. The study involves collection and analysis (testing) of data at regular follow-up visits with your doctor. These follow up visits with your doctor are no different than would otherwise occur if you did not enroll in this study. Principal Investigator(s):
    Jonathan S. Silver, MD

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Jean M. Byrne, RN.
    Circulating Tumor Cells in Patients with Primary Carcinoma of the Lung and Patients who are Candidates for Pulmonary Metastasectomy for Metastatic Colorectal, Breast, and Prostate Cancer [LCID Study Number: 2011-076] Why is this study being done? To determine if tumor cells can be isolated and treated from peripheral blood and blood from the part of lung that is being removed for the treatment of the tumor. Principal Investigator(s):
    Christina Williamson, MD

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Deborah J. Gannon,
    Frances A. Babcock.
    Renal Denervation in Patients with Uncontrolled Hypertension -SYMPLICITY HTN-3 [LCID Study Number: 2011-080] The purpose of this study is to provide additional information about a medical device intended to help treat high blood pressure in patients whose blood pressure is not controlled, despite treatment with multiple blood pressure medications. You are being considered for participation in this study because your blood pressure Principal Investigator(s):
    Sergio Waxman, MD

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Jean M. Byrne, RN,
    Judy E. Pendleton,
    Michele Rybicki, RN.
    The Leadless II Study: A Safety and Effectiveness Trial for a Leadless Pacemaker System [LCID Study Number: 2014-013] The purpose of this study is to evaluate the safety and effectiveness of a leadless pacemaker system in treating patients with slow heart rate or irregular heartbeats. The leadless pacemaker is implanted through a vein in the leg into the heart and is intended to help reduce certain complications associated with traditional pacemakers because it does not require a pocket under the collar bone and it does not have lead wires. This pacemaker is not approved by the Food and Drug Administration (FDA) and hence is considered investigational. Principal Investigator(s):
    Bruce G. Hook, MD

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Jean M. Byrne, RN.
  • Aetna logo     ThomsonReuters_TOP50_2012
  • Make an Appointment

    (781) 744-8000
  • Radio Highlights

    Hear about our Teamwork Approach

    Hear Terrie's Story

     

  • TAVR

     
    An innovative procedure to replace the aortic valve without traditional surgery.